Literature DB >> 16494642

Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis.

A-P Bai1, Q Ouyang, X-R Xiao, S-F Li.   

Abstract

Enteric microflora of ulcerative colitis patients becomes aberrant. The abnormal interaction between microflora and intestinal mucosal immune system leads the mucosal inflammation. Probiotic administration may recover the commensal microflora and normalise the host-microbial interaction. In this experiment, we cocultured colonic biopsies from active ulcerative colitis patients with bifidobacterium to investigate the modulation effect of probiotics on inflamed colonic tissues and its possible mechanism. Colonic biopsies from active ulcerative colitis were cocultured for 24 h with Bifidobacterium longum. Tumour necrosis factor (TNF)-alpha and interleukin (IL)-8 in supernatants were measured using enzyme-linked immunosorbent assays, the biopsies were fixed using paraffin and the expression of NF-kappaB P65 of tissues was studied using immunohistochemical staining. The concentrations of TNF-alpha and IL-8 in supernatants of tissues cocultured with probiotics were lower than those cultured alone. The number of lamina propria mononuclear cells (LPMC) with nuclear factor-kappa B (NF-kappaB) P65 positive in cocultured tissues was also decreased. When cocultured with inflamed tissues of active ulcerative colitis, probiotics could inhibit NF-kappaB activation in LPMC and down-regulate inflammatory cytokine secretion from inflamed tissues of active ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16494642     DOI: 10.1111/j.1368-5031.2006.00833.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  19 in total

Review 1.  Microbial host interactions in IBD: implications for pathogenesis and therapy.

Authors:  R Balfour Sartor; Marcus Muehlbauer
Journal:  Curr Gastroenterol Rep       Date:  2007-12

2.  Phosalone-induced inflammation and oxidative stress in the colon: Evaluation and treatment.

Authors:  Seyedeh Farnaz Ghasemi-Niri; Faheem Maqbool; Maryam Baeeri; Mahdi Gholami; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

Review 3.  Probiotics-host communication: Modulation of signaling pathways in the intestine.

Authors:  Carissa M Thomas; James Versalovic
Journal:  Gut Microbes       Date:  2010 May-Jun

4.  Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis.

Authors:  Sahar K Hegazy; Mohamed M El-Bedewy
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

Review 5.  Probiotics in the management of colonic disorders.

Authors:  Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2007-10

6.  Infant intestinal Enterococcus faecalis down-regulates inflammatory responses in human intestinal cell lines.

Authors:  Shugui Wang; Lydia Hui Mei Ng; Wai Ling Chow; Yuan Kun Lee
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 7.  The human gut microbiome: implications for future health care.

Authors:  James M Kinross; Alexander C von Roon; Elaine Holmes; Ara Darzi; Jeremy K Nicholson
Journal:  Curr Gastroenterol Rep       Date:  2008-08

8.  Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis.

Authors:  Aiping Bai; Nonghua Lu; Yuan Guo; Xianmin Fan
Journal:  Dig Dis Sci       Date:  2007-06-12       Impact factor: 3.199

Review 9.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

10.  Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis.

Authors:  Borja Ocón; Andrea Anzola; Mercedes Ortega-González; Antonio Zarzuelo; María D Suárez; Fermín Sánchez de Medina; Olga Martínez-Augustin
Journal:  Eur J Nutr       Date:  2012-09-01       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.